Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For ZD
Valuation Weak
14%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -29.32 1.95 2.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 78.37 2.93 1.64
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.28 41.47 41.36
Cash -1.96 16.38 16.71
Capex -6.94 -0.61 -0.57
Free Cash Flow -28.13 1.03 1.44
Revenue -19.49 6.86 8.52
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -2.85 0.74 0.77
Operating Margin -41.77 0.14 0.23
ROA -84.39 < 0.005 0.02
ROE -83.32 < 0.005 0.03
ROIC -67.42 < 0.005 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of ZD is permitted for members.
5 Growth
The "Growth Entry" for the Focus of ZD is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of ZD is permitted for members.